1、Lu, Min; Wu, Jiale; Song, Huaxin. PANDA as a novel therapeutic, PCT/CN2018/085190。进入中国、美国、欧盟、日本、澳大利亚、加拿大等全球主要国家，完成高水平转化。

2、Lu, Min; Wu, Jiale; Song, Huaxin. mp53 rescue compounds and methods of treating a p53 disorder, PCT/CN2019/070117。进入中国、美国、欧盟、日本、澳大利亚、加拿大等全球主要国家，完成高水平转化。

3、临床试验Arsenic Trioxide in Refractory Solid Tumors with Rescuable p53 Mutation (https://www.clinicaltrials.gov/ct2/show/NCT04869475)

4、临床试验Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (https://www.clinicaltrials.gov/ct2/show/NCT03855371)

5、临床试验Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations (https://www.clinicaltrials.gov/ct2/show/NCT04906031)

6、临床建议http://tp53.co.uk/interview-with-min-lu/

7、临床建议https://www.anticancerfund.org/en/blog/latest-news-about-drug-repurposing-oncology-4